NASDAQ:ACRS | Free Cash Flow | Aclaris Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2013-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$18.15M$13,000.00-$18.16M
2025-12-31-$13.13M$24,000.00-$13.16M
2025-03-31-$13.06M$43,000.00-$13.1M
2024-12-31-$8.94M$0.00-$8.94M
2024-03-31-$20.82M$135,000.00-$20.95M
2023-12-31-$6.76M$441,000.00-$7.2M
2023-03-31-$26.35M$553,000.00-$26.91M
2022-12-31-$19.12M$105,000.00-$19.22M
2022-03-31-$20.97M$164,000.00-$21.13M
2021-12-31-$17.08M$200,000.00-$17.28M
2021-03-31-$12.23M
2020-12-31-$8.86M$8,000.00-$8.87M
2020-03-31-$6.81M$124,000.00-$6.93M
2019-12-31-$20.39M$266,000.00-$20.66M
2019-03-31-$31.32M$284,000.00-$31.6M
2018-12-31-$27.25M$146,000.00-$27.39M
2018-03-31-$21.87M$298,000.00-$22.17M
2017-12-31-$18.21M$577,000.00-$18.79M
2017-03-31-$12.66M$195,000.00-$12.85M
2016-12-31-$8.07M$62,000.00-$8.13M
2016-03-31-$6.89M$40,000.00-$6.93M
2015-12-31-$4.14M$132,000.00-$4.27M
2015-03-31-$2.8M$77,000.00-$2.88M
2014-12-31-$2.76M$269,000.00-$3.03M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$47.11M$111,000.00-$47.22M
2024-12-31-$20.08M$121,000.00-$20.2M
2023-12-31-$78.33M$1.31M-$79.63M
2022-12-31-$67.57M$605,000.00-$68.17M
2021-12-31-$52.13M$308,000.00-$52.44M
2020-12-31-$38.63M$453,000.00-$39.09M
2019-12-31-$96.45M$1.61M-$98.06M
2018-12-31-$100.81M$1.36M-$102.17M
2017-12-31-$54.66M$1.24M-$55.9M
2016-12-31-$34.6M$232,000.00-$34.84M
2015-12-31-$20.37M$507,000.00-$20.88M
2014-12-31-$7.64M$417,000.00-$8.05M
2013-12-31-$4.92M